Latest Placebos news
Open-Label Placebo Plus Treatment Rationale Effective for PMS
posted March 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Open-Label Placebo May Reduce Fatigue in Cancer Survivors
posted February 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Open-label placebo may reduce fatigue in cancer survivors, according to a study published online Feb. 9 in Scientific Reports.
Open-Label Placebo Treatments Can Ease Chronic Low Back Pain
posted October 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients who knowingly took a placebo pill while undergoing traditional treatment for lower back pain had less pain and disability than those who received traditional treatment alone, according to a study published online Oct. 13 in Pain.
Branded Rx May Up the Power of Placebo
posted November 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
A brand-name label made a placebo tablet work as well as an active nonsteroidal anti-inflammatory drug, according to research published online Oct. 12 in Health Psychology.
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Related Articles
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma Monthly Specialist Briefings
Stay Connected
